JP2022523553A5 - - Google Patents
Info
- Publication number
- JP2022523553A5 JP2022523553A5 JP2021552599A JP2021552599A JP2022523553A5 JP 2022523553 A5 JP2022523553 A5 JP 2022523553A5 JP 2021552599 A JP2021552599 A JP 2021552599A JP 2021552599 A JP2021552599 A JP 2021552599A JP 2022523553 A5 JP2022523553 A5 JP 2022523553A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- tcr
- eso
- acid sequence
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813644P | 2019-03-04 | 2019-03-04 | |
| US62/813,644 | 2019-03-04 | ||
| PCT/IB2020/051809 WO2020178740A1 (en) | 2019-03-04 | 2020-03-03 | T cell receptors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523553A JP2022523553A (ja) | 2022-04-25 |
| JP2022523553A5 true JP2022523553A5 (https=) | 2023-03-13 |
| JP7748284B2 JP7748284B2 (ja) | 2025-10-02 |
Family
ID=72337471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552599A Active JP7748284B2 (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12527809B2 (https=) |
| EP (1) | EP3935175A4 (https=) |
| JP (1) | JP7748284B2 (https=) |
| KR (1) | KR20210149049A (https=) |
| CN (1) | CN113795583B (https=) |
| AU (1) | AU2020231693A1 (https=) |
| BR (1) | BR112021017491A2 (https=) |
| CA (1) | CA3132242A1 (https=) |
| IL (1) | IL286039A (https=) |
| MX (1) | MX2021010542A (https=) |
| SG (1) | SG11202109590VA (https=) |
| TW (1) | TW202100547A (https=) |
| WO (1) | WO2020178740A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| CN113795584B (zh) | 2019-03-04 | 2025-09-30 | 大学健康网络 | T细胞受体及其使用方法 |
| KR20210144737A (ko) | 2019-03-04 | 2021-11-30 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| MX2021011462A (es) | 2019-03-25 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de los mismos. |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2323632A1 (en) | 1998-03-13 | 1999-09-16 | Epimmune Inc. | Hla-binding peptides and their uses |
| CA2388337C (en) | 1999-10-22 | 2013-01-08 | Aventis Pasteur Limited | Method of inducing and/or enhancing an immune response to tumor antigens |
| EP2144935A2 (en) | 2007-03-29 | 2010-01-20 | Technion Research & Development Foundation Ltd. | Antibodies, methods and kits for diagnosing and treating melanoma |
| KR101363928B1 (ko) * | 2007-06-11 | 2014-02-19 | 고쿠리츠다이가쿠호진 미에다이가쿠 | 특이적 유전자 발현 방법 |
| EP2337795A2 (en) | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| JP5756792B2 (ja) | 2009-04-02 | 2015-07-29 | ヴァクソン バイオテックＶａｘｏｎ Ｂｉｏｔｅｃｈ | 免疫療法のための潜在性ｈｌａ−ａ２４エピトープの同定、最適化及び使用 |
| WO2011140284A2 (en) * | 2010-05-04 | 2011-11-10 | Fred Hutchinson Cancer Research Center | Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses |
| HRP20171164T1 (hr) | 2010-09-20 | 2017-10-20 | Biontech Cell & Gene Therapies Gmbh | Antigen-specifični t stanični receptori i t stanični epitopi |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| EP3604271A1 (en) | 2013-06-28 | 2020-02-05 | Auckland Uniservices Limited | Peptides for amino acid and peptide conjugates and conjugation process |
| KR101503341B1 (ko) | 2014-03-12 | 2015-03-18 | 국립암센터 | 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법 |
| AU2014407539B2 (en) | 2014-10-02 | 2020-10-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of isolating T cell receptors having antigenic specificity for a cancer-specific mutation |
| US20170333480A1 (en) | 2014-11-05 | 2017-11-23 | Board Of Regents, The University Of Texas System | Gene modified immune effector cells and engineered cells for expansion of immune effector cells |
| EP3067366A1 (en) | 2015-03-13 | 2016-09-14 | Max-Delbrück-Centrum Für Molekulare Medizin | Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1 |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| CN106632658B (zh) * | 2015-11-04 | 2020-10-27 | 广东香雪精准医疗技术有限公司 | 识别ny-eso-1抗原短肽的tcr |
| DK3399985T3 (da) * | 2016-01-06 | 2022-03-21 | Health Research Inc | Sammensætninger og biblioteker, der omfatter rekombinante T-cellereceptorer, og fremgangsmåder til anvendelse af rekombinante T-cellereceptorer |
| WO2017185169A1 (en) | 2016-04-27 | 2017-11-02 | University Health Network (Uhn) | Pept1de-hla complexes and methods of producing same |
| RU2019116312A (ru) * | 2016-11-14 | 2020-12-14 | Фред Хатчинсон Кэнсер Рисерч Сентер | Высокоаффинные tcr, специфичные к t-антигену полиомавируса клеток меркеля, и их применения |
| KR20210144737A (ko) | 2019-03-04 | 2021-11-30 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| KR20210144740A (ko) | 2019-03-04 | 2021-11-30 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| CN113795584B (zh) | 2019-03-04 | 2025-09-30 | 大学健康网络 | T细胞受体及其使用方法 |
| JP7748874B2 (ja) | 2019-03-04 | 2025-10-03 | ユニバーシティー ヘルス ネットワーク | Ｔ細胞受容体及びその使用方法 |
| US20220168346A1 (en) | 2019-03-04 | 2022-06-02 | University Health Network | T cell receptors and methods of use thereof |
| WO2020178739A1 (en) | 2019-03-04 | 2020-09-10 | University Health Network | T cell receptors and methods of use thereof |
| MX2021011462A (es) | 2019-03-25 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de los mismos. |
| CN114502580B (zh) | 2019-07-30 | 2025-10-17 | 大学健康网络 | Mhc ii类分子及其使用方法 |
| US20220275047A1 (en) | 2019-07-30 | 2022-09-01 | University Health Network | T cell receptors and methods of use thereof |
| BR112022001704A2 (pt) | 2019-07-30 | 2022-07-05 | Univ Health Network | Moléculas mhc de classe ii e métodos de uso das mesmas |
| CN114450302A (zh) | 2019-07-30 | 2022-05-06 | 大学健康网络 | Mhc ii类分子及其使用方法 |
| TWI869426B (zh) | 2019-07-30 | 2025-01-11 | 大學健康網絡 | Ｔ細胞受體及其使用方法 |
| KR20220087431A (ko) | 2019-07-30 | 2022-06-24 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| US20220291215A1 (en) | 2019-07-30 | 2022-09-15 | University Health Network | Methods of identifying t cell receptors |
| CN118475597A (zh) * | 2021-10-25 | 2024-08-09 | 加利福尼亚大学董事会 | 用于治疗胶质母细胞瘤的方法和组合物 |
-
2020
- 2020-03-03 EP EP20766869.0A patent/EP3935175A4/en active Pending
- 2020-03-03 US US17/436,933 patent/US12527809B2/en active Active
- 2020-03-03 AU AU2020231693A patent/AU2020231693A1/en active Pending
- 2020-03-03 CN CN202080024940.8A patent/CN113795583B/zh active Active
- 2020-03-03 CA CA3132242A patent/CA3132242A1/en active Pending
- 2020-03-03 JP JP2021552599A patent/JP7748284B2/ja active Active
- 2020-03-03 MX MX2021010542A patent/MX2021010542A/es unknown
- 2020-03-03 WO PCT/IB2020/051809 patent/WO2020178740A1/en not_active Ceased
- 2020-03-03 SG SG11202109590V patent/SG11202109590VA/en unknown
- 2020-03-03 BR BR112021017491A patent/BR112021017491A2/pt unknown
- 2020-03-03 KR KR1020217031569A patent/KR20210149049A/ko active Pending
- 2020-03-04 TW TW109107113A patent/TW202100547A/zh unknown
-
2021
- 2021-09-01 IL IL286039A patent/IL286039A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (https=) | ||
| JP2022523554A5 (https=) | ||
| JP2022524994A5 (https=) | ||
| JP2022523552A5 (https=) | ||
| JP2022524993A5 (https=) | ||
| JP2022523553A5 (https=) | ||
| JP2022523971A5 (https=) | ||
| Baxevanis et al. | Cancer immunotherapy | |
| Batlevi et al. | Novel immunotherapies in lymphoid malignancies | |
| Kershaw et al. | Gene-engineered T cells for cancer therapy | |
| JP2022524992A5 (https=) | ||
| US20200038443A1 (en) | Multi-function and multi-targeting car system and methods for use thereof | |
| Merhavi-Shoham et al. | Adoptive cell therapy for metastatic melanoma | |
| CN109694854B (zh) | 通用型嵌合抗原受体t细胞制备技术 | |
| JP2020509767A5 (https=) | ||
| Tsang et al. | Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. | |
| Shilyansky et al. | T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. | |
| Junghans | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective | |
| US20170232070A1 (en) | Combination Methods for Immunotherapy | |
| Murad et al. | Advances in the use of natural receptor-or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies | |
| CN115747156A (zh) | 用于得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖 | |
| JP2022543059A5 (https=) | ||
| US11951131B2 (en) | Anti-SLAMF7 chimeric antigen receptors | |
| JP2020533962A5 (https=) | ||
| JP2023548974A (ja) | Ｔ細胞抗原カプラを含む細胞及びその使用 |